rs75639119

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001164507.2(NEB):​c.9865G>A​(p.Gly3289Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00368 in 1,613,768 control chromosomes in the GnomAD database, including 36 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G3289D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0043 ( 8 hom., cov: 32)
Exomes 𝑓: 0.0036 ( 28 hom. )

Consequence

NEB
NM_001164507.2 missense

Scores

8
5
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:8

Conservation

PhyloP100: 6.03

Publications

7 publications found
Variant links:
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
NEB Gene-Disease associations (from GenCC):
  • nemaline myopathy 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Ambry Genetics
  • childhood-onset nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • typical nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • severe congenital nemaline myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009073287).
BP6
Variant 2-151627801-C-T is Benign according to our data. Variant chr2-151627801-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 95141.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00429 (653/152108) while in subpopulation NFE AF = 0.00404 (275/67996). AF 95% confidence interval is 0.00365. There are 8 homozygotes in GnomAd4. There are 406 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001164507.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NEB
NM_001164507.2
MANE Plus Clinical
c.9865G>Ap.Gly3289Ser
missense
Exon 69 of 182NP_001157979.2
NEB
NM_001164508.2
MANE Select
c.9865G>Ap.Gly3289Ser
missense
Exon 69 of 182NP_001157980.2
NEB
NM_001271208.2
c.9865G>Ap.Gly3289Ser
missense
Exon 69 of 183NP_001258137.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NEB
ENST00000397345.8
TSL:5 MANE Select
c.9865G>Ap.Gly3289Ser
missense
Exon 69 of 182ENSP00000380505.3
NEB
ENST00000427231.7
TSL:5 MANE Plus Clinical
c.9865G>Ap.Gly3289Ser
missense
Exon 69 of 182ENSP00000416578.2
NEB
ENST00000409198.5
TSL:5
c.9136G>Ap.Gly3046Ser
missense
Exon 66 of 150ENSP00000386259.1

Frequencies

GnomAD3 genomes
AF:
0.00430
AC:
653
AN:
151990
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000556
Gnomad AMI
AF:
0.0230
Gnomad AMR
AF:
0.000328
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000831
Gnomad FIN
AF:
0.0304
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00404
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00407
AC:
1013
AN:
249108
AF XY:
0.00411
show subpopulations
Gnomad AFR exome
AF:
0.000517
Gnomad AMR exome
AF:
0.000521
Gnomad ASJ exome
AF:
0.000199
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0260
Gnomad NFE exome
AF:
0.00345
Gnomad OTH exome
AF:
0.00165
GnomAD4 exome
AF:
0.00361
AC:
5283
AN:
1461660
Hom.:
28
Cov.:
32
AF XY:
0.00354
AC XY:
2577
AN XY:
727116
show subpopulations
African (AFR)
AF:
0.000568
AC:
19
AN:
33478
American (AMR)
AF:
0.000581
AC:
26
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000191
AC:
5
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000904
AC:
78
AN:
86256
European-Finnish (FIN)
AF:
0.0221
AC:
1179
AN:
53400
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5766
European-Non Finnish (NFE)
AF:
0.00345
AC:
3833
AN:
1111828
Other (OTH)
AF:
0.00232
AC:
140
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
350
699
1049
1398
1748
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00429
AC:
653
AN:
152108
Hom.:
8
Cov.:
32
AF XY:
0.00546
AC XY:
406
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.000554
AC:
23
AN:
41498
American (AMR)
AF:
0.000327
AC:
5
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000832
AC:
4
AN:
4810
European-Finnish (FIN)
AF:
0.0304
AC:
321
AN:
10564
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00404
AC:
275
AN:
67996
Other (OTH)
AF:
0.00189
AC:
4
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
31
62
94
125
156
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00286
Hom.:
0
Bravo
AF:
0.00218
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.000266
AC:
1
ESP6500EA
AF:
0.00402
AC:
33
ExAC
AF:
0.00347
AC:
419
EpiCase
AF:
0.00365
EpiControl
AF:
0.00208

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:5
Feb 09, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 22, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 27, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Nemaline myopathy 2 Uncertain:2Benign:1
Jan 08, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.

not provided Benign:2
Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NEB: BS2

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.63
BayesDel_addAF
Benign
-0.022
T
BayesDel_noAF
Pathogenic
0.20
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.20
T
Eigen
Pathogenic
0.97
Eigen_PC
Pathogenic
0.91
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Pathogenic
0.98
D
MetaRNN
Benign
0.0091
T
MetaSVM
Uncertain
-0.058
T
MutationAssessor
Pathogenic
3.8
H
PhyloP100
6.0
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-2.4
N
REVEL
Uncertain
0.47
Sift
Uncertain
0.0090
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.68
MVP
0.64
MPC
0.34
ClinPred
0.14
T
GERP RS
5.6
Varity_R
0.29
gMVP
0.51
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75639119; hg19: chr2-152484315; COSMIC: COSV50864996; API